Form D/A — Balanced Pharma Inc
0001838860-25-000007 · filed Sep 23, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,200,000
- Reported amount sold
- $3,200,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Balanced Pharma Inc
- CIK
- 1838860
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 18204 MAINSAIL POINTE
CORNELIUS, North Carolina 28031 - Phone
- (704) 650-0249
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
JOHN SCOTT KEADLE · Executive OfficerCORNELIUS, North Carolina Find on LinkedIn ↗
-
JOHN SELIG · DirectorCORNELIUS, North Carolina Find on LinkedIn ↗
-
MARK SEBREE · DirectorCORNELIUS, North Carolina Find on LinkedIn ↗
-
ATIF ZIA · DirectorCORNELIUS, North Carolina Find on LinkedIn ↗
-
RICHARD NONELLE · DirectorCORNELIUS, North Carolina Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗